EUCTR2008-000804-10-IT进行中（未招募）不适用
Valsartan 160 mg and hydrochlorothiazide 25 mg in subject suffering from arterial hypertension stage 1 or high normal with organ damage - ND
IVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II0 个研究点开始时间: 2009年5月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •-age between 18 and 65 -male -High-normal arterial blood pressure(PA 130-139/85-89 mmHg) -Essential hypertension of grade1
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Endocrine -Unable to practice stress-test by cicloergometer -Mellitus diabet -Anemia (Hb<12,5 g/dl) -Cardiac valvular e/o arhythmic disease
研究者
相似试验
已完成
4 期
Hypertension and Cardiovascular Risk FactorsHYPERTENSIONNCT00171782Novartis76
已完成
3 期
Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in HypertensionEssential HypertensionNCT00902538Daiichi Sankyo2,204
已完成
2 期
3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential HypertensionHypertensionNCT00153049Boehringer Ingelheim583
已完成
4 期
Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive PatientsHypertensionNCT00426478Novartis80
已完成
不适用
Effect of the Combination of varsartan with HCTZ on circadian BP rhythmChronic Kidney Disease (CKD)JPRN-UMIN000005601Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences30